Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drinking liquids in thyroid cancer therapy with I-131
IRCT2014051417684N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2014
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Phase 3 trial of iodine-131 in thyroid cancer, sponsored by Shiraz University of Medical Sciences. Started Jul 2014; status: completed.
02
Drugs
iodine-131
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on IRCT2014051417684N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014051417684N1.